Avidian Wealth Enterprises’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.77M Buy
6,746
+221
+3% +$58.3K 0.05% 234
2026
Q2
$1.44M Buy
6,525
+550
+9% +$152K 0.04% 260
2026
Q1
$1.76M Buy
5,975
+4,077
+215% +$1.21M 0.06% 212
2025
Q4
$518K Sell
1,898
-83
-4% -$22.6K 0.02% 366
2025
Q3
$535K Buy
1,981
+158
+9% +$43K 0.02% 354
2025
Q2
$503K Sell
1,823
-102
-5% -$27.7K 0.02% 332
2025
Q1
$511K Buy
1,925
+156
+9% +$38.5K 0.02% 307
2024
Q4
$411K Buy
1,769
+45
+3% +$10.3K 0.02% 339
2024
Q3
$380K Sell
1,724
-134
-7% -$27.7K 0.02% 354
2024
Q2
$365K Buy
1,858
+40
+2% +$8.26K 0.02% 355
2024
Q1
$391K Buy
1,818
+137
+8% +$28.8K 0.02% 308
2023
Q4
$354K Sell
1,681
-544
-24% -$116K 0.02% 315
2023
Q3
$446K Buy
2,225
+4
+0.2% +$795 0.03% 272
2023
Q2
$412K Buy
2,221
+90
+4% +$16.6K 0.03% 297
2023
Q1
$408K Sell
2,131
-349
-14% -$63.1K 0.02% 327
2022
Q4
$417K Buy
+2,480
New +$431K 0.03% 302

Other funds holding CME

Avidian Wealth Enterprises's CME Position: Q3 2026 in Review

Avidian Wealth Enterprises increased its CME Group (CME) stake by 3.4% in Q3 2026, buying an estimated $58.3K and bringing the position to 6,746 shares worth $1.77M. The position accounts for 0.05% of the portfolio, ranked #234.

Avidian Wealth Enterprises first reported a position in CME in Q4 2022 and has held it in 16 quarters since. 59 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Avidian Wealth Enterprises held 6,746 shares of CME Group worth $1.77M as of Q3 2026.
  • Avidian Wealth Enterprises bought 221 CME Group shares in Q3 2026, an estimated $58.3K.
  • CME Group made up 0.05% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #234 holding.
  • Avidian Wealth Enterprises first reported a position in CME Group in Q4 2022 and has held it in 16 quarters since.
  • 59 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.